Innovenn
  • Company
    • About Innovenn
    • Our Team
    • Partnerships and Affiliations
    • Culture
    • Careers
  • Consulting Services
    • Software as a Medical Device (SaMD) Development
      • Clinical Decision Support Software (CDSS)
      • Digital Therapeutics (DTx)
      • Validation of DHTs (Digital Health Technologies) for use in Clinical Investigations
      • Clinical Evaluation for SaMD
      • Data Governance for SaMD
      • Regulatory Services for SaMD Products
      • Medical Device Cybersecurity
    • Medical Device Development Consulting
      • The Process of Medical Device Concept Development and Feasibility
      • Design Control Management
      • Clinical Evaluation
      • Clinical Investigation
      • Risk Management
      • Bluetooth Validation
    • Human Factors and Usability Engineering
    • Regulatory Planning and Submissions Consulting
      • Medical & Regulatory Writing
      • 510(k) & FDA Guidance
      • The LDT (Laboratory Developed Test) Regulatory Landscape
      • Premarket Approval (PMA)
      • De Novo
      • Importance of Clinical Data in Premarket Approval
      • FDA Label Regulations
      • EU MDR
      • UK MDR
    • Drug Development Consulting
      • Prescription to Over-the-Counter Switch
    • Program and Technical Project Management
      • Patient-Centered Design and Approach to Product Development
    • Quality Management Systems (QMS) Consulting
      • QMS Audit Services: Preparation, Response and Corrective Action Support
    • Specialized Life Sciences Consulting
  • Who We Work With
    • Software as a Medical Device (SaMD) and Digital Therapeutics
    • Medical Device
    • Pharmaceutical
    • Biotechnology
    • Venture-backed Startups
  • Products Portfolio
    • Software as a Medical Device (SaMD) and Digital Therapeutics
    • Machine Learning and Artificial Intelligence
    • Medical Devices
    • Combination Products
    • Wearable Medical Devices
  • Resources
    • Testimonials
    • News
    • Case Studies
    • Videos
    • Blogs
    • Events
  • Contact
  • Linkedin
  • Menu Menu
  • Company
    • About Innovenn
    • Our Team
    • Partnerships and Affiliations
    • Culture
    • Careers
  • Consulting Services
    • Software as a Medical Device (SaMD) Development
      • Clinical Decision Support Software (CDSS)
      • Digital Therapeutics (DTx)
      • Validation of DHTs (Digital Health Technologies) for use in Clinical Investigations
      • Clinical Evaluation for SaMD
      • Data Governance for SaMD
      • Regulatory Services for SaMD Products
      • Medical Device Cybersecurity
    • Medical Device Development Consulting
      • The Process of Medical Device Concept Development and Feasibility
      • Design Control Management
      • Clinical Evaluation
      • Clinical Investigation
      • Risk Management
      • Bluetooth Validation
    • Human Factors and Usability Engineering
    • Regulatory Planning and Submissions Consulting
      • Medical & Regulatory Writing
      • 510(k) & FDA Guidance
      • The LDT (Laboratory Developed Test) Regulatory Landscape
      • Premarket Approval (PMA)
      • De Novo
      • Importance of Clinical Data in Premarket Approval
      • FDA Label Regulations
      • EU MDR
      • UK MDR
    • Drug Development Consulting
      • Prescription to Over-the-Counter Switch
    • Program and Technical Project Management
      • Patient-Centered Design and Approach to Product Development
    • Quality Management Systems (QMS) Consulting
      • QMS Audit Services: Preparation, Response and Corrective Action Support
    • Specialized Life Sciences Consulting
  • Who We Work With
    • Software as a Medical Device (SaMD) and Digital Therapeutics
    • Medical Device
    • Pharmaceutical
    • Biotechnology
    • Venture-backed Startups
  • Products Portfolio
    • Software as a Medical Device (SaMD) and Digital Therapeutics
    • Machine Learning and Artificial Intelligence
    • Medical Devices
    • Combination Products
    • Wearable Medical Devices
  • Resources
    • Testimonials
    • News
    • Case Studies
    • Videos
    • Blogs
    • Events
  • Contact
  • LinkedIn
Blog - Latest News
Get to Know Us

Patient Centric Culture

Nurse holding hands with elderly patient

At Innovenn, a key principle that guides everything we do is: putting patients first. Our patient-centric culture founded on deep empathy and care for the patient and their preferences provides the foundation upon which successful technologies are developed. By focusing on the needs, preferences, and experiences of patients, we can drive innovation that increases patient satisfaction followed by increased product adoption.

Patient-centricity puts the individual at the heart of their healthcare journey. At Innovenn, we aim to help design, develop, and deliver solutions that meet technical and regulatory requirements, are easy to use safely, but also address the physical, emotional, and mental well-being of the people these products serve. This approach results in quality products that are more intuitive, usable, accessible, and, most significantly, effective in meeting patient needs; they become the preferred choice, a key advantage in an era where patient-driven decisions shape adoption.

Fostering a Patient-Centric Culture Drives Innovation

Understanding Patient Needs

Patient-centricity begins with listening to patients and truly understanding their needs and the obstacles they face. Engaging with key stakeholders (e.g., industry, HCPs advocacy groups, caregivers, and patients) along the patient’s care journey elucidates insights into the challenges patients face in the real world each day. Understanding these challenges guides design and product functionality, helping to address unmet needs and improve the patient experience.

Optimizing Design and Usability

No matter what the product, whether a wearable, a surgical tool, or a diagnostic device, or a drug/device combination, usability is of the utmost priority. Keeping the patient at the center of the design and understanding their needs and preferences results in the development of products that optimize ease of use and accessibility. Products that are intuitive and easy to use help healthcare providers deliver better care while also empowering patients to optimize their own health.

Better Outcomes

Patient-centered design results in products that are easier to use, but, importantly, it also enhances efficacy and improves outcomes.1 A recent study found that by improving a health app’s usability, the developers lowered the barriers to patient adoption.2 By keeping the focus on the outcomes patients value most, including, for example, their quality of life, managing their discomfort and pain, and/or time to recuperate, companies can develop products that directly improve lives. Examples include integrating features like remote monitoring, personalized recommendations, or real-time feedback to foster patient engagement and continuity of care.

Fostering Trust

Trust is fundamental to patient satisfaction with their healthcare. Patients that feel their needs, challenges, and priorities are understood are more likely to adopt new technologies. For example, a recent study found that empowerment, self-management, and personalization in digital health tools (DHT) were identified as the primary factors contributing to patient uptake of the tools.3 Involving patients throughout the product development lifecycle is key to making sure their voices are heard and, by doing so, earns their trust.

Patient-Centricity Beyond Product Development

As described above, patient-centricity is a critical piece to defining healthcare products and the requirements for development, but it should also extend to all aspects of operations. Below are some ways industry can foster a patient-first culture beyond product development:

  • Patient Preference Information: Patient Preference Information (PPI) uncovers what features of a medical device are most valuable to patients. It considers various patient perspectives when evaluating the benefits and risks of a device. Recently, FDA issued guidance on Incorporating Voluntary Patient Preference Information over the Total Product Life Cycle. This guidance provides clarity and context for the voluntary collection of PPI. It defines PPI as, “qualitative or quantitative assessments of the relative desirability or acceptability to patients of specified alternatives or choices among outcomes or other attributes that differ among alternative health interventions.”4 Industry can voluntarily participate in the collection of this information to inform FDA and develop more patient centric products.
  • Customer Education: Provide access to ongoing education, training, and support. Patients are better able to make informed decisions about their health when they have access to clear and easy to understand information.
  • Study Design: By focusing on the patient’s needs, preferences, and challenges during study design, industry can align the studies with real-world use scenarios. Whether the study is a Human Factors Study or a Clinical Evaluation, this approach not only improves patient engagement but can also increase adherence to treatment. Patient-centered study design can provide valuable insights into the product’s performance in diverse, real-world environments, and also decrease the occurrence of use errors and advance clinical outcomes.
  • Recruitment for Studies: Having the patients’ needs and preferences understood and considered before recruiting for studies, such as Human Factors testing or clinical trials, is crucial to obtaining high-quality data. At Innovenn, we prepare our studies through our uniquely curated patient empathy program, we focus on understanding patients’ needs, experiences, and symptoms and translate that understanding into action. This approach gives the team a unique perspective on the patient’s needs, which are thoughtfully incorporated into the study planning phase. When patients feel heard and valued, they are more likely to engage fully, providing accurate and representative data that informs product development.
  • Study Execution: During the execution of studies, creating an environment where patients feel safe and respected is key to obtaining valuable insights. By continuing to prioritize empathy and patient well-being throughout the study process, the study setting can make participants feel comfortable sharing their experiences. This leads to more accurate, reliable data that can directly inform the development of products that truly meet patients’ needs.
  • Clinical Trials: Clinical trials and clinical investigations should be representative and inclusive to produce the most meaningful results. Increasing study design flexibility and patient accessibility to trials helps drive broader patient representation. Considerations for decentralization, remote versus in person visits, technology implementation and reductions in patient burden are several design aspects to consider. Implementing diverse recruitment strategies, providing language accessibility, and collaborating with patient advocacy can facilitate wider demographic participation.
  • Collaboration with Healthcare Providers: Build relationships with doctors, nurses, and healthcare providers to align with the needs of those delivering care to patients. This leads to insights on how the products can easily integrate into the care setting.
  • Post-Market Monitoring and Feedback: After product launch, continue to monitor and gather feedback from patients. Patient-centricity should be rooted in an iterative approach, where adjustments or updates are made to keep products relevant to the user’s needs over time.

The Future of Patient-Centric Culture

As industry moves forward, patient-centricity must continue to be a guiding force. The emergence of technologies like artificial intelligence, wearable devices, and telehealth have the ability to transform patient care. Even so, focusing on the true unmet needs and patient preferences will enable these advancements to serve the health ecosystem and the patients to improve outcomes.

The journey begins with empathy and understanding the experiences and challenges of those who are directly impacted by the healthcare solutions being developed. At Innovenn, we’ve adopted this patient-centric mindset not only to help our clients develop better products but to help improve patient lives.


References:

  1. Sawant, S., Joshi, P., & Sawant, S. (2023). Usability testing of Healthcare Devices: A review of the current UX methods used for usability testing of healthcare devices. Proceedings of the Human Factors and Ergonomics Society Annual Meeting, 67(1), 1078-1083.
  2. Madanian S, Nakarada-Kordic I, Reay S, Chetty T. Patients’ perspectives on digital health tools. PEC Innov. 2023 May 26;2:100171. doi: 10.1016/j.pecinn.2023.100171. PMID: 37384154; PMCID: PMC10294099.
  3. Rochat J, Ehrler F, Siebert JN, Ricci A, Garretas Ruiz V, Lovis C
    Usability Testing of a Patient-Centered Mobile Health App for Supporting and Guiding the Pediatric Emergency Department Patient Journey: Mixed Methods Study
    JMIR Pediatr Parent 2022;5(1):e25540
  4. Food and Drug Administration (FDA). (2024). Draft guidance for industry: Incorporating Voluntary Patient Preference Information over the Total Product Life Cycle.
April 2, 2025/by Innovenn
https://innovenn.com/wp-content/uploads/2025/04/patient-centric-culture-resized.jpeg 438 1000 Innovenn /wp-content/uploads/2023/07/Innovenn-Primary-Logo-300x75.png Innovenn2025-04-02 10:43:502025-05-21 15:22:06Patient Centric Culture

Stay Informed

Join the 4000+ readers who stay informed with our monthly newsletter.

Sign Me Up

Search Search

Categories

  • Blog (4)
  • Get to Know Us (4)
  • News (2)
  • Press Release (1)
  • SaMD (1)
Innovenn logo
Where healthcare innovation intersects with improved patient outcomes
Contact Us
Contact Innovenn

Global reach from Wisconsin HQ. Serving clients in the US, EU, UK & Canada

6410  Enterprise Lane
Suite 230
Madison, WI 53719

608-203-9748

info@innovenn.com

Stay Informed

Sign up to get the latest industry news, insights and tips.

Sign Me Up
Search Search
© 2026 All rights reserved. | Privacy Policy | Terms of Use | WordPress Web Design by Bizzy Bizzy
Link to: Innovation and Excellence in the Next Decade of Precision Medicine Link to: Innovation and Excellence in the Next Decade of Precision Medicine Innovation and Excellence in the Next Decade of Precision MedicineDoctor examining images of a human body Link to: Innovenn and Ateleris GmbH Announce Strategic Collaboration Link to: Innovenn and Ateleris GmbH Announce Strategic Collaboration Innovenn and Ateleris GmbH Announce Strategic Collaboration
Scroll to top Scroll to top Scroll to top

This site uses cookies. By continuing to browse the site, you are agreeing to our use of cookies.

Accept settingsHide notification onlySettings

Cookie and Privacy Settings



How we use cookies

We may request cookies to be set on your device. We use cookies to let us know when you visit our websites, how you interact with us, to enrich your user experience, and to customize your relationship with our website.

Click on the different category headings to find out more. You can also change some of your preferences. Note that blocking some types of cookies may impact your experience on our websites and the services we are able to offer.

Essential Website Cookies

These cookies are strictly necessary to provide you with services available through our website and to use some of its features.

Because these cookies are strictly necessary to deliver the website, refusing them will have impact how our site functions. You always can block or delete cookies by changing your browser settings and force blocking all cookies on this website. But this will always prompt you to accept/refuse cookies when revisiting our site.

We fully respect if you want to refuse cookies but to avoid asking you again and again kindly allow us to store a cookie for that. You are free to opt out any time or opt in for other cookies to get a better experience. If you refuse cookies we will remove all set cookies in our domain.

We provide you with a list of stored cookies on your computer in our domain so you can check what we stored. Due to security reasons we are not able to show or modify cookies from other domains. You can check these in your browser security settings.

Google Analytics Cookies

These cookies collect information that is used either in aggregate form to help us understand how our website is being used or how effective our marketing campaigns are, or to help us customize our website and application for you in order to enhance your experience.

If you do not want that we track your visit to our site you can disable tracking in your browser here:

Other external services

We also use different external services like Google Webfonts, Google Maps, and external Video providers. Since these providers may collect personal data like your IP address we allow you to block them here. Please be aware that this might heavily reduce the functionality and appearance of our site. Changes will take effect once you reload the page.

Google Webfont Settings:

Google Map Settings:

Google reCaptcha Settings:

Vimeo and Youtube video embeds:

Other cookies

The following cookies are also needed - You can choose if you want to allow them:

Privacy Policy

You can read about our cookies and privacy settings in detail on our Privacy Policy Page.

Privacy Policy
Accept settingsHide notification only

Sign up to get the latest industry news, insights and tips.

Name(Required)